Novel quinazoline derivatives as SOS1 inhibitors and use thereof

The present invention relates to a novel quinazoline derivative compound that serves as an SOS1 inhibitor, and a use thereof, and more specifically to: a novel quinazoline derivative compound having inhibitory activity against SOS1 binding to RAS family proteins and/or RAC1; a pharmacologically acce...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, Won Jeoung, KIM, Min Jeong, BAE, In Hwan, KIM, Ji Sook, PARK, Won Gi, CHOI, Jae Yul, AHN, Young Gil
Format Patent
LanguageEnglish
Published 12.09.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention relates to a novel quinazoline derivative compound that serves as an SOS1 inhibitor, and a use thereof, and more specifically to: a novel quinazoline derivative compound having inhibitory activity against SOS1 binding to RAS family proteins and/or RAC1; a pharmacologically acceptable salt thereof; or a pharmaceutical composition containing the compound.
AbstractList The present invention relates to a novel quinazoline derivative compound that serves as an SOS1 inhibitor, and a use thereof, and more specifically to: a novel quinazoline derivative compound having inhibitory activity against SOS1 binding to RAS family proteins and/or RAC1; a pharmacologically acceptable salt thereof; or a pharmaceutical composition containing the compound.
Author KIM, Ji Sook
KIM, Min Jeong
KIM, Won Jeoung
AHN, Young Gil
CHOI, Jae Yul
PARK, Won Gi
BAE, In Hwan
Author_xml – fullname: KIM, Won Jeoung
– fullname: KIM, Min Jeong
– fullname: BAE, In Hwan
– fullname: KIM, Ji Sook
– fullname: PARK, Won Gi
– fullname: CHOI, Jae Yul
– fullname: AHN, Young Gil
BookMark eNrjYmDJy89L5WRw8MsvS81RKCzNzEusys_JzEtVSEktyixLLMksSy1WSCxWCPYPNlTIzMvITMosyS8CCuWlKJQWpyqUZKQWpean8TCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSSeMdQIwMjQxMDS1NDU0dLY-JUAQCc8DO6
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2021409515A9
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2021409515A93
IEDL.DBID EVB
IngestDate Fri Sep 20 10:12:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2021409515A93
Notes Application Number: AU20210409515
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240912&DB=EPODOC&CC=AU&NR=2021409515A9
ParticipantIDs epo_espacenet_AU2021409515A9
PublicationCentury 2000
PublicationDate 20240912
PublicationDateYYYYMMDD 2024-09-12
PublicationDate_xml – month: 09
  year: 2024
  text: 20240912
  day: 12
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies HANMI PHARMACEUTICAL CO., LTD
RelatedCompanies_xml – name: HANMI PHARMACEUTICAL CO., LTD
Score 3.5708919
Snippet The present invention relates to a novel quinazoline derivative compound that serves as an SOS1 inhibitor, and a use thereof, and more specifically to: a novel...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Novel quinazoline derivatives as SOS1 inhibitors and use thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240912&DB=EPODOC&locale=&CC=AU&NR=2021409515A9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKeqbTsXLlIDSt6Jdu9I8DN16YQi2w22yt9FLygojnbad4K_3JHS6p72FBMJJyDlfvly-A_CA8c-MkxC5SRIbSFAiqoamFakdi7EuRcCgqVT79M3h1HiddWcNWG7-wkid0G8pjogeFaO_lzJer_4PsRz5trJ4jDKsyp-9Sc9RanaM8ES1juIMeu4ocAJbsW1kkor_LtqEtBOid5_uwb7YSAulffdjIP6lrLZBxTuBgxH2x8tTaDDegiN7k3utBYdv9ZU3FmvvK87gxc_XbEk-q4yHPyLZDiMJLqC11O4uSFiQcTDWSMYXWZSJLDok5AmpCkbELo_l6Tnce-7EHqpoyvxv5PP-dNtu_QKaPOfsEsiTnjILuYZmMGREOrNoZFhxjNwpTi2jo11Be1dP17ubb-BYzKUqMyW0oVl-VewWsbeM7uSU_QJOX4cB
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ1dT8IwFIZPEI14p6hBRW2i2d2i-wC3C6KwsUyFQQQMd2QfXVxCOnQbJv56TxtQrrhr2qTpmp2-fdb1PQC3uP41w8hHNolCHQElMGW_aQSyalDaMFEwzFi4fXpNd6K_TBvTEszXd2GET-i3MEfEiAox3nOxXi_-P2LZ4t_K7C5IsCp9dMYtW1rRMcqTqaiS3Wl1hwN7YEmWhSQpeW-8jVs7oXq3zR3YfUAoFLD03uH3UhabouIcwt4Q-2P5EZQoq0LFWudeq8J-f3XkjcVV9GXH8OSlSzonn0XC_B-ebIeSCF-gpfDuzoifkdFgpJCEfSRBwrPoEJ9FpMgo4bs8msYncON0x5Yr41Bmf08-a082x62dQpmljNaA3GsxNZA1FJ0iEWnUMAPdCENkpzA2dFU5g_q2ns63N19DxR33e7Pes_d6AQd8XmWRNaEO5fyroJeow3lwJabvF8Nxies
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+quinazoline+derivatives+as+SOS1+inhibitors+and+use+thereof&rft.inventor=KIM%2C+Won+Jeoung&rft.inventor=KIM%2C+Min+Jeong&rft.inventor=BAE%2C+In+Hwan&rft.inventor=KIM%2C+Ji+Sook&rft.inventor=PARK%2C+Won+Gi&rft.inventor=CHOI%2C+Jae+Yul&rft.inventor=AHN%2C+Young+Gil&rft.date=2024-09-12&rft.externalDBID=A9&rft.externalDocID=AU2021409515A9